NanoViricides, Inc. (NASDAQ:NNVC)

PRESS RELEASE

published on 05/20/2024 at 12:30, 1 year 10 months ago

Lethally RSV Infected Animals Orally Treated with NV-387 Showed Normal Lung Histology, Indicating Potential Cure
NanoViricides, Inc. announces strong antiviral activity of NV-387 against RSV, Influenza A, and Coronaviruses in lethal lung infection models, potentially offering a cure for RSV infection

NV-387 Clinical Trials NanoViricides Inc. Antiviral RSV
BRIEF

published on 05/15/2024 at 12:35, 1 year 10 months ago

NanoViricides Reports Financial Update and Advancements in Clinical Trials

NanoViricides NV-387 Financial Report Clinical Trials Antiviral Treatment
BRIEF

published on 05/15/2024 at 12:35, 1 year 10 months ago

NanoViricides annonce une mise à jour financière et des progrès dans les essais cliniques

NanoViricides NV-387 Rapport Financier Essais Cliniques Traitement Antiviral
PRESS RELEASE

published on 05/15/2024 at 12:30, 1 year 10 months ago

NanoViricides Has Filed its Quarterly Report
NanoViricides, Inc. reports advancing NV-387 to Phase II Clinical Trial for RSV infection treatment. Financial status and future plans discussed

NV-387 Phase II Clinical Trial NanoViricides Inc. RSV Infection Antiviral Nanomedicines
BRIEF

published on 05/14/2024 at 12:35, 1 year 10 months ago

NanoViricides Announces Breakthrough in RSV Treatment with NV-387

NanoViricides NV-387 Pharmaceutical Innovation RSV Treatment Antiviral Research
BRIEF

published on 05/14/2024 at 12:35, 1 year 10 months ago

NanoViricides annonce une percée dans le traitement du VRS avec le NV-387

NanoViricides NV-387 Innovation Pharmaceutique Traitement Contre Le VRS Recherche Antivirale
PRESS RELEASE

published on 05/14/2024 at 12:30, 1 year 10 months ago

A Novel Broad-Spectrum Antiviral with Activity Against RSV
NanoViricides, Inc. announces complete survival of animals lethally infected with RSV in lungs upon NV-387 oral treatment. Promising antiviral activity shown in study

NV-387 NanoViricides Inc. Antiviral Treatment RSV Infection Lung Infection
BRIEF

published on 05/08/2024 at 12:35, 1 year 10 months ago

NanoViricides Announces Promising Results with NV-387 in Potentially Treating Smallpox and Mpox

NanoViricides NV-387 Tecovirimat Smallpox Mpox
BRIEF

published on 05/08/2024 at 12:35, 1 year 10 months ago

NanoViricides annonce des résultats prometteurs avec le NV-387 dans le traitement potentiel de la variole et de la Mpox

NanoViricides NV-387 Tecovirimat Variole Mvariole
PRESS RELEASE

published on 05/08/2024 at 12:30, 1 year 10 months ago

A Novel Broad-Spectrum Antiviral with Activity Against Smallpox/Mpox
NanoViricides reports NV-387 shows strong orthopoxvirus activity against Smallpox/Mpox via inhalation and skin transmission. Study highlights efficacy in lethal animal models, supporting clinical development potential

NanoViricides NV-387 Clinical Development Orthopoxvirus Antiviral

Published on 03/20/2026 at 23:00, 5 hours 22 minutes ago

Cypher Announces Private Placement
Published on 03/20/2026 at 21:30, 6 hours 52 minutes ago

Sky Gold Sets Options
Published on 03/20/2026 at 21:15, 7 hours 7 minutes ago

Earthwise Minerals Announces Private Placement
Published on 03/20/2026 at 13:30, 14 hours 52 minutes ago

Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/20/2026 at 12:30, 15 hours 52 minutes ago

CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals

View all ACCESSWIRE

Published on 03/20/2026 at 22:45, 5 hours 37 minutes ago

Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 7 hours 17 minutes ago

Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 21:05, 7 hours 17 minutes ago

Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $4.3 billion
Published on 03/20/2026 at 21:00, 7 hours 22 minutes ago

BRP Unveils the Winners of its 6th International Design Challenge
Published on 03/20/2026 at 20:05, 8 hours 17 minutes ago

INVESTOR ALERT: Goeasy Ltd. Shareholder Class Action

View all EQS

Published on 03/20/2026 at 19:00, 9 hours 22 minutes ago

AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 9 hours 22 minutes ago

AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 10 hours 7 minutes ago

Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 10 hours 7 minutes ago

Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
Published on 03/20/2026 at 17:45, 10 hours 37 minutes ago

Cie du Bois Sauvage : Jaarverslag 2025

View all LES ECHOS COMFI WIRE

News